# Clinical Evaluation of Arthrocentesis, Combination of Platelet-Rich Plasma and Cyclooxygenase Enzyme-2 Inhibitor in Treatment of Temporo-Mandibular Joint Anterior Displacement

> **NCT07463404** · PHASE3 · COMPLETED · sponsor: **Suez Canal University** · enrollment: 20 (actual)

## Conditions studied

- Temporomandibular Joint Internal Derangement

## Interventions

- **COMBINATION_PRODUCT:** Inject Combination of Platelet-Rich Plasma and Cyclooxygenase Enzyme-2 Inhibitor after arthrocentesis

## Key facts

- **NCT ID:** NCT07463404
- **Lead sponsor:** Suez Canal University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-01
- **Primary completion:** 2025-06-01
- **Final completion:** 2025-11-25
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2026-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07463404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07463404, "Clinical Evaluation of Arthrocentesis, Combination of Platelet-Rich Plasma and Cyclooxygenase Enzyme-2 Inhibitor in Treatment of Temporo-Mandibular Joint Anterior Displacement". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07463404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*